Miquel Vila-Perelló, SpliceBio CEO
June 11, 2025 03:00 AM EDT
Financing
Startups
Cell/Gene Tx

Gene ther­a­py biotech Splice­Bio gets $135M short­ly af­ter start­ing first clin­i­cal tri­al

Kyle LaHucik

Biotech Correspondent

In the dif­fi­cult field of gene ther­a­pies, some biotech star­tups are still reel­ing in large amounts of cap­i­tal.

Barcelona-based Splice­Bio is the lat­est. The 40 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ex­clu­sive: Kennedy picks for vac­cine ad­vi­so­ry board were paid ex­perts against Mer­ck in civ­il cas­es

RFK Jr. names eight new ACIP mem­bers, in­clud­ing pop­u­lar vac­cine crit­ic Robert Mal­one

BioN­Tech to ac­quire Cure­Vac in all-stock deal val­ued at $1.25B

In­smed aims to raise $750M in one of the largest stock of­fer­ings this year

ADC Ther­a­peu­tics re­veals lay­offs, $100M PIPE; Third Har­mon­ic seeks buy­er for as­set

sponsored

McKesson leads the charge in rev­o­lu­tion­iz­ing pre­ci­sion on­col­o­gy in com­mu­ni­ty prac­tices

A service from the Financial Times